Transcription of Ipca Laboratories Ltd.
{{id}} {{{paragraph}}}
Example: marketing
Ipca Laboratories Ltd.
Ipca Laboratories PresentationJune 2018 Company OverviewIncorporation:1949 Present Management :Since 1975 Total income F. Y. 2017-18:` Crs / US$ 505 MnExports F. Y. 2017-18:` Crs / US$ 243 MnExports F. Y. 2017-18:` Crs / US$ 243 MnNumber of Employees:13,294 including 6131in marketing and distributionBusiness Model:Fully integrated pharmaceuticalcompany producing Brandedand Generics Formulations,APIs and IntermediatesFive Years Highlights2013-14 2014-15 2015-16 2016-17 2017-18 Domestic Income ( ` Crs )1, , , , , Income (US $ Mn) Income ( ` Crs )2, , , , , Income ( ` Crs )2, , , , , Income (US $ Mn) Income ( ` Crs )3, , , , , Income (US $ Mn) Profit After Tax ( ` Crs ) Profit After Tax (US $ Mn) FacilitiesFormulationsManufacturing FacilitiesFormulationsLocationD
International APIs –Drug Master Files Sr. No. Name of the API US- FDA EU Canada- HPFB WHO Japan - PMDA Australia EDQM 1 Atenolol aaa aa aaa a aaa CEP aaaa 2 Artemether aaaa a aaa
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
BRAND / GENERIC NAME FORMULATION, BRAND / GENERIC NAME FORMULATION PRESENTATION, DRUG CLASSIFICATION SYSTEMS, Presentation, Generic, 2013 Formulation switching of antiepileptic, 2013 . Formulation switching of antiepileptic, GUIDANCE FOR INDUSTRY ON FIXED DOSE, GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS, FDA Regulation of Pharmaceutical Marketing